Company / Shares Outstanding
Edgewise Therapeutics, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
102.9M
FY2025
5-year range
37.5M / 102.9M
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#92 of 212
Health Care
What the data says
At 102930744.00, Edgewise Therapeutics, Inc.'s shares outstanding ranks #121 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 739004.00 in FY2020 to 102930744.00 in FY2025.
Based on SEC 10-K filings.
102930744.00 in FY2025 with a 5-year CAGR of +168.4%.
Increased from 63723600.00 to 102930744.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +24.3%
- 5-Year CAGR
- +168.4%
- 10-Year CAGR
- -
Sector benchmark
#121 of 212 in Health CareTop 57% of 212This company 102.9M Sector average 306.0M
▼
-66.4% below sector average
Key checks
Key Insights
- Edgewise Therapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 11.4% year-over-year.
- Ranks #92 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.82 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 102.9M | +11.4% |
| FY2024 | 92.4M | +45.0% |
| FY2023 | 63.7M | +18.9% |
| FY2022 | 53.6M | +42.8% |
| FY2021 | 37.5M | +4978.0% |
| FY2020 | 739.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026